No credit card. No commitment.
5000+ G2 reviews
SomantiX BV
Research
Founded in 2003
Utrecht, Utrecht
aglaia-biomedical.comSomantiX BV
ResearchFounded in 2003Utrecht, Utrecht
AlumniSomantiX BV's financial review
SomantiX BV's Revenue (Yearly)
10.1M
Employees
10
Total Funding
65M
Last Funding Round
65M
SomantiX BV information
SomantiX B.V. is a Dutch biotech company focusing on the identification and development of new angiogenesis inhibitors for the treatment of solid cancers through targeting of tumor blood vessels.Somantix' screening platform in combination with the binder generation technologies allows validation of new therapeutic targets and development of new cancer medicines.
SomantiX BV industries
Research
Biotechnology research
SomantiX BV's financial review
SomantiX BV's Revenue (Yearly)
10.1M
Employees
10
Total Funding
65M
Last Funding Round
65M
Notable Alumni
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
